Andrew Seidman

Andrew Seidman

UNVERIFIED PROFILE

Are you Andrew Seidman?   Register this Author

Register author
Andrew Seidman

Andrew Seidman

Publications by authors named "Andrew Seidman"

Are you Andrew Seidman?   Register this Author

96Publications

1393Reads

38Profile Views

The Evolution of Clinical Trials in Metastatic Breast Cancer: Design Features and Endpoints That Matter.

Am Soc Clin Oncol Educ Book 2020 Mar;40:1-11

U.S. Food and Drug Administration, Silver Spring, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_280451DOI Listing
March 2020

Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer.

Int J Cancer 2019 08 12;145(4):882-893. Epub 2019 Feb 12.

Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.32139
Publisher Site
http://dx.doi.org/10.1002/ijc.32139DOI Listing
August 2019

Author's reply to: Comparing the performance of gene expression assays in breast cancer.

Int J Cancer 2019 08 6;145(4):1163-1164. Epub 2019 Apr 6.

Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32289
Publisher Site
http://dx.doi.org/10.1002/ijc.32289DOI Listing
August 2019

Adjuvant chemotherapy for node negative, high Recurrence Score breast cancer: in defense of de-escalation.

NPJ Breast Cancer 2019 12;5:24. Epub 2019 Aug 12.

Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-019-0119-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690957PMC
August 2019

Reducing threat responses to help-seeking information: Influences of self-affirmations and reassuring information.

J Couns Psychol 2019 Apr 15;66(3):375-383. Epub 2018 Oct 15.

Department of Psychology, Iowa State University.

View Article

Download full-text PDF

Source
http://doi.apa.org/getdoi.cfm?doi=10.1037/cou0000313
Publisher Site
http://dx.doi.org/10.1037/cou0000313DOI Listing
April 2019

Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.

Clin Breast Cancer 2018 10 21;18(5):353-361. Epub 2017 Dec 21.

Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.12.009DOI Listing
October 2018

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.

Clin Breast Cancer 2018 10 15;18(5):387-394. Epub 2018 Mar 15.

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682312PMC
October 2018

Self-affirming values to increase student veterans' intentions to seek counseling.

J Couns Psychol 2018 Oct 19;65(5):653-660. Epub 2018 Jul 19.

Department of Psychology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1037/cou0000289DOI Listing
October 2018

National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer.

J Clin Oncol 2018 Sep 13:JCO1800242. Epub 2018 Sep 13.

Andrew D. Seidman, Memorial Sloan Kettering Cancer Center; Dawn L. Hershman, Columbia University, New York, NY; Louise Bordeleau, Hamilton Health Sciences and Canadian Cancer Trials Group, Hamilton, Ontario, Canada; Louis Fehrenbacher, Kaiser Permanente, Vallejo, CA; William E. Barlow, Cancer Research and Biostatistics, Seattle, WA; Jane Perlmutter, Gemini Group, Ann Arbor, MI; Lawrence Rubinstein, Jennifer Fallas Hayes, and Larissa A. Korde, National Cancer Institute; Lynn Pearson Butler, The Emmes Corporation, Rockville; Suparna B. Wedam, Julia A. Beaver, and Laleh Amiri-Kordestani, US Food and Drug Administration, Silver Spring; Jo Anne Zujewski, JZ Oncology, Bethesda, MD; Mary Lou Smith, Research Advocacy Network, Plano, TX; Meredith M. Regan, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; and Priya Rastogi, University of Pittsburgh Medical Center, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00242
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00242DOI Listing
September 2018

Living with chronic pain: perceptions of breast cancer survivors.

Breast Cancer Res Treat 2018 May 19;169(1):133-140. Epub 2018 Jan 19.

Memorial Sloan Kettering Cancer Center, 1429 First Avenue, New York, NY, 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4670-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147242PMC
May 2018

An Important Step Forward for Biosimilars in Cancer Treatment.

JAMA Oncol 2017 07;3(7):989-990

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York3Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.6789DOI Listing
July 2017

Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.

Clin Breast Cancer 2017 02 25;17(1):23-28. Epub 2016 Jul 25.

Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15268209163017
Publisher Site
http://dx.doi.org/10.1016/j.clbc.2016.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266701PMC
February 2017

Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study.

Neuro Oncol 2015 Feb 11;17(2):289-95. Epub 2014 Jul 11.

Memorial Sloan-Kettering Cancer Center, New York, New York (A.M., C.G.M., A.S., V.T., A.D.S.); Cleveland Clinic, Cleveland, Ohio (D.M.P., R.J.W.); Texas Tech University Health Sciences Center, Amarillo, Texas (H.R.T., R.S., R.B., P.R.L., Q.R.S.); Center for Cancer Research National Cancer Institute, Bethesda, Maryland (P.S.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288517PMC
February 2015

In reply.

Oncologist 2015 Jan;20(1):88

Nottingham University Hospital, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294611PMC
January 2015

Antidepressants for cognitive impairment in schizophrenia--a systematic review and meta-analysis.

Schizophr Res 2014 Nov 18;159(2-3):385-94. Epub 2014 Sep 18.

The Zucker Hillside Hospital, Psychiatry, North Shore-Long Island Jewish Health System, Glen Oaks, NY, USA; Hofstra North Shore LIJ School of Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Manhasset, NY, USA; Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2014.08.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252251PMC
November 2014

A pooled analysis of gemcitabine plus docetaxel versus capecitabine plus docetaxel in metastatic breast cancer.

Oncologist 2014 May 4;19(5):443-52. Epub 2014 Apr 4.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Nottingham University Hospital, Nottingham, United Kingdom; Lilly China, Shanghai, People's Republic of China; Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012969PMC
May 2014

Phase II trial of patupilone in patients with brain metastases from breast cancer.

Neuro Oncol 2014 Apr 26;16(4):579-83. Epub 2014 Jan 26.

Cleveland Clinic Lerner College of Medicine, Case Western Reserve University (D.M.P., M.S.A.); The Rose Ella Burkhardt Brain Tumor and NeuroOncology Center, Neurological Institute, Cleveland Clinic (D.M.P., M.S.A.); Taussig Cancer Institute, Cleveland Clinic (D.M.P., M.S.A., P.E.); Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio(P.E.); Memorial Sloan-Kettering Cancer Center, New York, New York(C.M., A.C., A.D.S.); Massachusetts General Hospital, Boston, Massachusetts(A.E.); Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan(C.V.P.); Seidman Cancer Center of University Hospitals, Case Medical Center, Cleveland, Ohio(J.B.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/not305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956359PMC
April 2014

Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases.

Breast J 2013 Jan-Feb;19(1):96-9. Epub 2012 Nov 23.

Department of Medicine, Gastrointestinal Oncology Service, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12050DOI Listing
June 2013

The search for an elusive uniform strategy for a heterogeneous disease: lesson learned?

Authors:
Andrew D Seidman

J Clin Oncol 2013 May 8;31(14):1707-8. Epub 2013 Apr 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.48.6894DOI Listing
May 2013

Limited overall survival in patients with brain metastases from triple negative breast cancer.

Breast J 2012 Jul-Aug;18(4):345-50. Epub 2012 May 21.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2012.01246.xDOI Listing
April 2013

Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer.

J Clin Neurophysiol 2013 Apr;30(2):199-203

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNP.0b013e3182767d3bDOI Listing
April 2013

Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer.

Cancer 2012 Jul 15;118(13):3254-9. Epub 2011 Nov 15.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26654DOI Listing
July 2012

How long is long enough?

Authors:
Andrew D Seidman

J Clin Oncol 2011 Jun 4;29(16):2129-30. Epub 2011 Apr 4.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2010.34.0455
Publisher Site
http://dx.doi.org/10.1200/JCO.2010.34.0455DOI Listing
June 2011

The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?

Curr Oncol Rep 2011 Feb;13(1):17-25

Evelyn H. Lauder Breast and Imaging Center, Memorial Sloan-Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-010-0137-9DOI Listing
February 2011

Adjuvant taxanes: more to the story.

Clin Breast Cancer 2010 Sep;10 Suppl 2:S41-9

Solid Tumor Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2010.s.011DOI Listing
September 2010

Brain metastases from breast cancer.

Authors:
Andrew D Seidman

Clin Adv Hematol Oncol 2010 Sep;8(9):595-7

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
September 2010

Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity.

Cancer Immunol Immunother 2010 Jun 6;59(6):885-97. Epub 2010 Feb 6.

Cellular Immunology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-009-0815-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268513PMC
June 2010

A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects.

J Cancer Res Clin Oncol 2009 Sep 1;135(9):1215-21. Epub 2009 Mar 1.

Integrative Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-009-0562-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751581PMC
September 2009

Evolving approaches to metastatic breast cancer previously treated with anthracyclines and taxanes.

Clin Breast Cancer 2009 Jun;9 Suppl 2:S58-65

Department of Breast Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2009.s.006DOI Listing
June 2009

Beyond cytotoxic chemotherapy for the first-line treatment of HER2-negative, hormone-insensitive metastatic breast cancer: current status and future opportunities.

Clin Breast Cancer 2008 Jun;8(3):215-23

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152682091170511
Publisher Site
http://dx.doi.org/10.3816/CBC.2008.n.024DOI Listing
June 2008

Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer.

Mol Diagn Ther 2007 ;11(6):355-60

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF03256259DOI Listing
April 2008

Point: combination versus single-agent chemotherapy: the argument for sequential single agents.

J Natl Compr Canc Netw 2007 Sep;5(8):668-72

Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2007.0068DOI Listing
September 2007

Emerging targeted therapies for breast cancer.

Hematol Oncol Clin North Am 2007 Apr;21(2):321-40

Breast Unit, Department of Medicine, The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2007.03.005DOI Listing
April 2007

Taxanes in breast cancer: an update.

Curr Oncol Rep 2007 Jan;9(1):22-30

Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/bf02951422DOI Listing
January 2007

Cardiac dysfunction associated with trastuzumab.

Expert Opin Drug Saf 2006 Sep;5(5):619-29

Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1023/A:1016140729725
Web Search
http://www.tandfonline.com/doi/full/10.1517/14740338.5.5.619
Publisher Site
http://dx.doi.org/10.1517/14740338.5.5.619DOI Listing
September 2006

A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancer.

Clin Breast Cancer 2006 Aug;7(3):270-7

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2006.n.040DOI Listing
August 2006

Systemic treatment of breast cancer. Two decades of progress.

Authors:
Andrew D Seidman

Oncology (Williston Park) 2006 Aug;20(9):983-90; discussion 991-2, 997-8

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
August 2006

Is trastuzumab active following conventional adjuvant chemotherapy in HER2-positive early breast cancer?

Authors:
Andrew D Seidman

Nat Clin Pract Oncol 2006 Apr;3(4):178-9

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ncponc0460
Publisher Site
http://dx.doi.org/10.1038/ncponc0460DOI Listing
April 2006

Current status of dose-dense chemotherapy for breast cancer.

Authors:
Andrew D Seidman

Cancer Chemother Pharmacol 2005 Nov;56 Suppl 1:78-83

Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-005-0109-1
Publisher Site
http://dx.doi.org/10.1007/s00280-005-0109-1DOI Listing
November 2005

"Will weekly work"? Seems to be so....

Authors:
Andrew D Seidman

J Clin Oncol 2005 Sep 8;23(25):5873-4. Epub 2005 Aug 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.031DOI Listing
September 2005

Emerging targeted therapies for breast cancer.

Oncology (Williston Park) 2005 Apr;19(5):611-8

Joan and Sanford I. Weill Medical College, Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
April 2005

Two regimens of docetaxel for metastatic breast cancer.

Curr Oncol Rep 2005 Jan;7(1)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-005-0016-yDOI Listing
January 2005

Gemcitabine and docetaxel in metastatic breast cancer.

Authors:
Andrew D Seidman

Oncology (Williston Park) 2004 Dec;18(14 Suppl 12):13-6

Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
December 2004

New advances in taxane therapy: the next generation.

Authors:
Andrew D Seidman

J Natl Compr Canc Netw 2004 Sep;2 Suppl 3:S-5-8

Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
September 2004

Single-agent gemcitabine in the treatment of advanced breast cancer.

Clin Breast Cancer 2004 Jan;4 Suppl 3:S101-6

Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/cbc.2004.s.002DOI Listing
January 2004

Cardiac effects of adjuvant therapy for early breast cancer.

Semin Oncol 2003 Dec;30(6):730-9

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2003.08.024DOI Listing
December 2003

Introduction. Single-agent or combination chemotherapy in metastatic breast cancer.

Authors:
Andrew Seidman

Oncology (Williston Park) 2003 Dec;17(12 Suppl 14):9-14

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
December 2003

Dose-dense treatment prolongs disease-free survival of women with node positive breast cancer.

Cancer Treat Rev 2003 Oct;29(5):453-6

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Newyork, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0305-7372(03)00164-6DOI Listing
October 2003

Incorporating oral capecitabine into the treatment of breast cancer. Introduction.

Oncologist 2002 ;7 Suppl 6:1-3

Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.7-suppl_6-1DOI Listing
April 2003

Combination versus sequential single-agent therapy in metastatic breast cancer.

Oncologist 2002 ;7 Suppl 6:13-9

ICRF Breast Cancer Biology Unit, Guy's and St. Thomas' Hospital, London, UK.

View Article

Download full-text PDF

Source
April 2003

Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer?

Oncologist 2002 ;7 Suppl 6:20-8

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.7-suppl_6-20DOI Listing
April 2003

Monotherapy options in the management of metastatic breast cancer.

Authors:
Andrew D Seidman

Semin Oncol 2003 Apr;30(2 Suppl 3):6-10

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonc.2003.37268DOI Listing
April 2003

Critical review of current treatment strategies for advanced hormone insensitive breast cancer.

Cancer Invest 2002 ;20 Suppl 2:1-14

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1081/cnv-120014881DOI Listing
December 2002

HER2 testing and correlation with efficacy of trastuzumab therapy.

Oncology (Williston Park) 2002 Oct;16(10):1340-8, 1351-2; discussion 1352, 1355-8

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
October 2002

Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer.

J Clin Oncol 2002 May;20(9):2319-26

Breast Cancer Medicine Service, the Pathology Department, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.08.125DOI Listing
May 2002

Cardiac dysfunction in the trastuzumab clinical trials experience.

J Clin Oncol 2002 Mar;20(5):1215-21

Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.20.5.1215DOI Listing
March 2002

An update on epidermal growth factor receptor inhibitors.

Curr Oncol Rep 2002 Jan;4(1):47-55

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-002-0047-6DOI Listing
January 2002